Pacira Pharmaceuticals (PCRX) PT Lowered to $57 at Jefferies
Tweet
Share
E-mail
Get Alerts PCRX Hot Sheet
Price: $25.59 -0.93%
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 3
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 3
Join SI Premium – FREE
Jefferies lowered its price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $57.00 (from $59.00) while maintaining a Buy rating.
Analyst Edward Chung remains positive on the name although Symphony Health data suggests lower Q3 revenues which drive the target cut.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elastic NV. (ESTC) PT Raised to $107 at Stifel as Sales Revenue Accelerates
- Best Buy (BBY) PT Raised to $95 at DA Davidson Following Earnings
- Rubrik Inc (RBRK) PT Raised to $115 at BMO Capital
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
